← All organizations
Highest phase reached
Phase 1
First clinical trial
Apr 30, 2018Last known activity
Apr 30, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT03468049Study directorEarly Phase 1Apr 30, 2018
- NCT03468049Overall official - principal investigatorEarly Phase 1Apr 30, 2018
- NCT03468049Reponsible party - principal investigatorEarly Phase 1Apr 30, 2018
- NCT03468049Lead sponsorEarly Phase 1Apr 30, 2018
Details
- Last known activity
- Apr 30, 2018